WO2001032886A2 - Starch branching enzymes - Google Patents
Starch branching enzymes Download PDFInfo
- Publication number
- WO2001032886A2 WO2001032886A2 PCT/CA2000/001276 CA0001276W WO0132886A2 WO 2001032886 A2 WO2001032886 A2 WO 2001032886A2 CA 0001276 W CA0001276 W CA 0001276W WO 0132886 A2 WO0132886 A2 WO 0132886A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- starch
- wheat
- endosperm
- branching enzyme
- plant
- Prior art date
Links
- 229920002472 Starch Polymers 0.000 title claims abstract description 173
- 235000019698 starch Nutrition 0.000 title claims abstract description 170
- 239000008107 starch Substances 0.000 title claims abstract description 166
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 22
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 22
- 239000008187 granular material Substances 0.000 claims abstract description 185
- 235000021307 Triticum Nutrition 0.000 claims abstract description 114
- 108090000344 1,4-alpha-Glucan Branching Enzyme Proteins 0.000 claims abstract description 48
- 102000003925 1,4-alpha-Glucan Branching Enzyme Human genes 0.000 claims abstract description 48
- 235000007340 Hordeum vulgare Nutrition 0.000 claims abstract description 39
- 241000228158 x Triticosecale Species 0.000 claims abstract description 39
- 235000019714 Triticale Nutrition 0.000 claims abstract description 35
- 235000007238 Secale cereale Nutrition 0.000 claims abstract description 27
- 241000209140 Triticum Species 0.000 claims abstract description 15
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 11
- 241000209056 Secale Species 0.000 claims abstract 6
- 108090000623 proteins and genes Proteins 0.000 claims description 105
- 102000004169 proteins and genes Human genes 0.000 claims description 80
- 241000196324 Embryophyta Species 0.000 claims description 50
- 238000000034 method Methods 0.000 claims description 45
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 24
- 239000012634 fragment Substances 0.000 claims description 20
- 239000000523 sample Substances 0.000 claims description 18
- 108020004414 DNA Proteins 0.000 claims description 13
- 238000006243 chemical reaction Methods 0.000 claims description 13
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 11
- 238000009826 distribution Methods 0.000 claims description 9
- 238000009396 hybridization Methods 0.000 claims description 7
- 230000014616 translation Effects 0.000 claims description 7
- 235000013339 cereals Nutrition 0.000 claims description 5
- 229920000642 polymer Polymers 0.000 claims description 5
- 238000013519 translation Methods 0.000 claims description 5
- 230000003321 amplification Effects 0.000 claims description 4
- 230000002902 bimodal effect Effects 0.000 claims description 4
- 230000001965 increasing effect Effects 0.000 claims description 4
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 4
- 238000013518 transcription Methods 0.000 claims description 4
- 230000035897 transcription Effects 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 230000003247 decreasing effect Effects 0.000 claims description 3
- 239000008103 glucose Substances 0.000 claims description 3
- 230000001939 inductive effect Effects 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 238000012986 modification Methods 0.000 claims description 3
- 150000001720 carbohydrates Chemical class 0.000 claims description 2
- 235000014633 carbohydrates Nutrition 0.000 claims description 2
- 238000006731 degradation reaction Methods 0.000 claims description 2
- 239000000796 flavoring agent Substances 0.000 claims description 2
- 235000019634 flavors Nutrition 0.000 claims description 2
- 150000002632 lipids Chemical class 0.000 claims description 2
- 239000000049 pigment Substances 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 claims description 2
- 230000002335 preservative effect Effects 0.000 claims description 2
- 230000009145 protein modification Effects 0.000 claims description 2
- 238000001243 protein synthesis Methods 0.000 claims description 2
- 230000017854 proteolysis Effects 0.000 claims description 2
- 229960005486 vaccine Drugs 0.000 claims description 2
- 241000209219 Hordeum Species 0.000 claims 11
- 239000003205 fragrance Substances 0.000 claims 1
- 230000008685 targeting Effects 0.000 claims 1
- 239000002299 complementary DNA Substances 0.000 abstract description 34
- 240000005979 Hordeum vulgare Species 0.000 abstract description 28
- 108010029485 Protein Isoforms Proteins 0.000 abstract description 17
- 102000001708 Protein Isoforms Human genes 0.000 abstract description 17
- 244000098338 Triticum aestivum Species 0.000 description 104
- 235000018102 proteins Nutrition 0.000 description 64
- 238000004458 analytical method Methods 0.000 description 57
- 101100121891 Pisum sativum SBEI gene Proteins 0.000 description 41
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 28
- 210000004027 cell Anatomy 0.000 description 23
- 108090000765 processed proteins & peptides Proteins 0.000 description 22
- 244000082988 Secale cereale Species 0.000 description 21
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 20
- 150000001413 amino acids Chemical group 0.000 description 20
- 239000000499 gel Substances 0.000 description 19
- 229940088598 enzyme Drugs 0.000 description 18
- 239000000872 buffer Substances 0.000 description 16
- 230000000694 effects Effects 0.000 description 16
- 238000003119 immunoblot Methods 0.000 description 16
- 238000013508 migration Methods 0.000 description 16
- 230000005012 migration Effects 0.000 description 16
- 102000004196 processed proteins & peptides Human genes 0.000 description 16
- 239000000047 product Substances 0.000 description 16
- 101100504555 Pisum sativum SBEII gene Proteins 0.000 description 15
- 229920001184 polypeptide Polymers 0.000 description 15
- 239000002773 nucleotide Substances 0.000 description 14
- 230000014509 gene expression Effects 0.000 description 13
- 125000003729 nucleotide group Chemical group 0.000 description 13
- 208000002109 Argyria Diseases 0.000 description 11
- 238000003757 reverse transcription PCR Methods 0.000 description 11
- 239000000284 extract Substances 0.000 description 10
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 239000012528 membrane Substances 0.000 description 8
- 238000010186 staining Methods 0.000 description 8
- 229920001503 Glucan Polymers 0.000 description 7
- 230000021759 endosperm development Effects 0.000 description 7
- 239000013604 expression vector Substances 0.000 description 7
- 239000003550 marker Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 238000012163 sequencing technique Methods 0.000 description 6
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 5
- 108020004705 Codon Proteins 0.000 description 5
- 241000170793 Phalaris canariensis Species 0.000 description 5
- 235000005632 Phalaris canariensis Nutrition 0.000 description 5
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 5
- 244000061456 Solanum tuberosum Species 0.000 description 5
- 235000002595 Solanum tuberosum Nutrition 0.000 description 5
- 240000008042 Zea mays Species 0.000 description 5
- 230000000903 blocking effect Effects 0.000 description 5
- 239000011536 extraction buffer Substances 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 229910052740 iodine Inorganic materials 0.000 description 5
- 239000011630 iodine Substances 0.000 description 5
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 238000001712 DNA sequencing Methods 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 240000007594 Oryza sativa Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- 108010065084 Phosphorylase a Proteins 0.000 description 4
- 238000012300 Sequence Analysis Methods 0.000 description 4
- 208000035199 Tetraploidy Diseases 0.000 description 4
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- 102000004139 alpha-Amylases Human genes 0.000 description 4
- 108090000637 alpha-Amylases Proteins 0.000 description 4
- 229940024171 alpha-amylase Drugs 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000002950 deficient Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 230000000977 initiatory effect Effects 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 235000009973 maize Nutrition 0.000 description 4
- 108020004999 messenger RNA Proteins 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 230000001629 suppression Effects 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- HKJKONMZMPUGHJ-UHFFFAOYSA-N 4-amino-5-hydroxy-3-[(4-nitrophenyl)diazenyl]-6-phenyldiazenylnaphthalene-2,7-disulfonic acid Chemical compound OS(=O)(=O)C1=CC2=CC(S(O)(=O)=O)=C(N=NC=3C=CC=CC=3)C(O)=C2C(N)=C1N=NC1=CC=C([N+]([O-])=O)C=C1 HKJKONMZMPUGHJ-UHFFFAOYSA-N 0.000 description 3
- 241001522110 Aegilops tauschii Species 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 108010054278 Lac Repressors Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 108700026244 Open Reading Frames Proteins 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 3
- 108091034057 RNA (poly(A)) Proteins 0.000 description 3
- 240000000581 Triticum monococcum Species 0.000 description 3
- 235000007251 Triticum monococcum Nutrition 0.000 description 3
- 238000000246 agarose gel electrophoresis Methods 0.000 description 3
- 230000000692 anti-sense effect Effects 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 239000013599 cloning vector Substances 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 108010004047 granule-bound starch synthase I Proteins 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 230000007030 peptide scission Effects 0.000 description 3
- 230000008488 polyadenylation Effects 0.000 description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 230000001131 transforming effect Effects 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- 239000013598 vector Substances 0.000 description 3
- 229940100445 wheat starch Drugs 0.000 description 3
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 3
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- 238000011537 Coomassie blue staining Methods 0.000 description 2
- 239000003298 DNA probe Substances 0.000 description 2
- 108700024394 Exon Proteins 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- 238000010240 RT-PCR analysis Methods 0.000 description 2
- 101100043635 Solanum tuberosum SS2 gene Proteins 0.000 description 2
- 101100478426 Streptomyces albogriseolus ssi gene Proteins 0.000 description 2
- 101100366698 Streptomyces violaceus vsi gene Proteins 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 240000002805 Triticum turgidum Species 0.000 description 2
- 235000007247 Triticum turgidum Nutrition 0.000 description 2
- 244000152061 Triticum turgidum ssp durum Species 0.000 description 2
- 235000003404 Triticum turgidum ssp. durum Nutrition 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000009402 cross-breeding Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 239000012149 elution buffer Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000010191 image analysis Methods 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 239000002985 plastic film Substances 0.000 description 2
- 210000002706 plastid Anatomy 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000000159 protein binding assay Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000003351 stiffener Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- QRXMUCSWCMTJGU-UHFFFAOYSA-L (5-bromo-4-chloro-1h-indol-3-yl) phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP([O-])(=O)[O-])=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-L 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 101000642812 Arabidopsis thaliana Starch synthase 1, chloroplastic/amyloplastic Proteins 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 108020001027 Ribosomal DNA Proteins 0.000 description 1
- 101000642819 Solanum tuberosum Soluble starch synthase 1, chloroplastic/amyloplastic Proteins 0.000 description 1
- 108010039811 Starch synthase Proteins 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 235000007244 Zea mays Nutrition 0.000 description 1
- MJOQJPYNENPSSS-XQHKEYJVSA-N [(3r,4s,5r,6s)-4,5,6-triacetyloxyoxan-3-yl] acetate Chemical compound CC(=O)O[C@@H]1CO[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O MJOQJPYNENPSSS-XQHKEYJVSA-N 0.000 description 1
- JUGOREOARAHOCO-UHFFFAOYSA-M acetylcholine chloride Chemical compound [Cl-].CC(=O)OCC[N+](C)(C)C JUGOREOARAHOCO-UHFFFAOYSA-M 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- HXXFSFRBOHSIMQ-VFUOTHLCSA-N alpha-D-glucose 1-phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(O)=O)[C@H](O)[C@@H](O)[C@@H]1O HXXFSFRBOHSIMQ-VFUOTHLCSA-N 0.000 description 1
- 238000012197 amplification kit Methods 0.000 description 1
- 230000003625 amylolytic effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 229920000704 biodegradable plastic Polymers 0.000 description 1
- 230000008436 biogenesis Effects 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 229920006238 degradable plastic Polymers 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 230000030279 gene silencing Effects 0.000 description 1
- 238000012226 gene silencing method Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229950010772 glucose-1-phosphate Drugs 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 229960000789 guanidine hydrochloride Drugs 0.000 description 1
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 210000003000 inclusion body Anatomy 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 238000004900 laundering Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000009465 prokaryotic expression Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 230000004960 subcellular localization Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8245—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified carbohydrate or sugar alcohol metabolism, e.g. starch biosynthesis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
- C12N9/107—1,4-Alpha-glucan branching enzyme (2.4.1.18)
Definitions
- the invention relates to the field of plant molecular biology, particularly to enzymes of starch bio-synthesis.
- the endosperm of wheat, barley, rye and triticale contain large A-type and small B-type starch granules at maturity 1 .
- the large A-type starch granules are more than 10 ⁇ m in diameter and lenticular in shape, while B- type starch granules are less than 10 ⁇ m in diameter and roughly spherical in shape 2 .
- A- and B-type starch granules have significantly different chemical compositions and functional properties 3 , wheat cultivars with predominantly A- or B-type starch granules would be very useful to the food and non-food industries.
- A-type starch granules are produced in amyloplast at about four to five days- post-anthesis (DP A), and their number increases until 12 to 14 DP A 4 . Subsequently, the A-type starch granules grow in size to an eventual diameter of from 10 ⁇ m to more than 36 ⁇ m. The number of A-type starch granules per endosperm is constant from about 15 DPA to maturity.
- B-type starch granules are actively initiated about 14-16 DPA. Both the number and size of B-type starch granules increase until wheat grain matures. The diameter of B-type starch granules is less than 10 ⁇ m 2 .
- the mechanisms controlling the initiation and size growth of A- and B-type starch granules are unknown. Based on the current knowledge about starch granule synthesis, several mechanisms could be proposed.
- the initiation and size growth of A- and B-type starch granules may be controlled by different isoforms of starch synthases (SS), starch branching enzymes (SBE), and debranching enzymes (DBE). These enzymes are involved in the biogenesis of plant starch granules 5 .
- Starch branching enzyme ( ⁇ -l,4-glucan-6-glycosyltransf erase; EC 2.4.1.18, SBE) is a key enzyme in the starch biosynthesis pathway.
- the enzyme acts on glucose polymers and catalyses excision and transfer of glucan chains to the same or other glucan molecules. Translocated chains are attached to the polymer through ⁇ -l,6-glucosidic bonds to form branches on the ⁇ -l,4-linked glucose backbone.
- All of the reported SBE from plants to date can be divided into two classes, SBEI and SBEII, based on their amino acid sequences 10 .
- SBEs are in the 80-100 kDa molecular mass range and, like all enzymes of the ⁇ -amylase family, carry a ( ⁇ ) ⁇ barrel domain with four highly conserved regions at the active site 11 .
- Analysis of plants with reduced SBEII activity and enzyme assays performed with purified SBEI and SBEII proteins suggest that the two enzyme classes differ in their enzymatic specificity 12 13 .
- the biochemical data suggest that SBEI favours transfer of long glucan chains and acts primarily on amylose, whereas SBEII produces shorter branches and prefers amylopectin as substrate 1 15 16 .
- SBEII produces shorter branches and prefers amylopectin as substrate 1 15 16 .
- the exact role of the different SBE classes in the formation of the branched glucan polymers in planta is not clear. There is no previous evidence to suggest that there are SBEs specific to A- or B-type starch granules.
- the invention provides a starch branching enzyme that is bound to A-type starch granules in wheat, rye, barley or triticale endosperm.
- the invention provides a DNA sequence encoding one of the starch branching enzymes that is bound to A-type starch granules in wheat, rye, barley or triticale endosperm.
- the invention provides a method for increasing the concentration of A-type starch granules in endosperm of a wheat, rye, barley or triticale plant by over-expressing in the plant a gene encoding a starch branching enzyme that is bound to A-type starch granules.
- the invention provides a method for decreasing the concentration of A-type starch granules in endosperm of a wheat, rye, barley or triticale plant by suppressing the activity of a starch branching enzyme that is bound to A-type starch granules.
- the invention provides a method for decreasing the concentration of A-type starch granules in endosperm of a wheat, rye, barley or triticale plant by suppressing the transcription and/ or translation of a gene encoding a starch branching enzyme that is bound to A-type starch granules in wheat, rye, barley or triticale endosperm.
- the invention provides a method of modifying starch granule morphology in a plant expressing a gene encoding a starch branching enzyme that is bound to A-type starch granules in wheat, rye, barley or triticale endosperm.
- the invention provides a method for analysing a plant to determine the presence or absence of DNA encoding granule bound starch branching enzyme, comprising the steps of: providing a probe capable of hybridising with a DNA encoding a starch branching enzyme that is bound to A-type starch granules in wheat, rye, barley or triticale endosperm; exposing the probe to sequences of DNA derived from the genome of the plant; and detecting whether hybridisation with the probe has occurred.
- the invention provides a method for analysing a plant to determine the presence or absence of transcripts encoding granule bound starch branching enzyme, comprising the steps of: providing a probe capable of hybridising with mRNA encoding a starch branching enzyme that is bound to A-type starch granules in wheat, rye, barley or triticale endosperm; exposing the probe to RNA prepared from the plant or used in in situ hybridisation analysis, and detecting whether hybridisation with the probe has occurred; providing specific primer for detection of transcripts encoding a granule bound starch branching enzyme in wheat; where detection is accomplished by RT-PCR analysis.
- the invention provides an antibody raised to a starch branching enzyme that is bound to A-type starch granules in wheat, rye, barley or triticale endosperm.
- the invention provides a method for analysing a plant to determine the presence or absence of granule bound starch branching enzyme, comprising the steps of: exposing the proteins of the plant to an antibody raised to a starch branching enzyme that is bound to A-type starch granules in wheat, rye, barley or triticale endosperm; and detecting whether the antibody has bound a starch branching enzyme that is bound to A-type starch granules in wheat, rye, barley or triticale endosperm.
- the invention also relates to a method of genetically transforming a plant so that the plant expresses a starch branching enzyme that is bound to A-type starch granules in wheat, barley, or triticale endosperm.
- the invention further relates to a genetically modified plant expressing a starch branching enzyme that is bound to A-type starch granules in wheat, barley, or triticale endosperm.
- the invention also relates to a genetically modified plant having within its genome a hybrid gene, wherein the hybrid gene comprises a DNA sequence encoding a starch branching enzyme that is bound to A-type starch granules in wheat, barley or triticale endosperm, or a fragment thereof, fused to a passenger-gene.
- Figure 1 shows a schematic alignment of pABEI and pRN60 cDNA.
- Hatched area of pABEI coding region represents sequence encoding a putative transit peptide and horizontal arrows on the pRN60 cDNA show location of imperfect direct repeats.
- the four black areas within the coding region represent sequences encoding the highly conserved regions of enzymes belonging to the ⁇ -amylase family 11 .
- DNA fragments used as probes in DNA and RNA hybridisations are indicated below.
- Figure 2 shows RNA gel analysis of Sbel expression during wheat kernel development.
- RNA (20 ⁇ g) prepared from developing kernels harvested at different DPA. The blot was hybridised with probe 2 ( Figure 1) and estimated sizes of hybridising RNA species are shown to the left. Migration of RNA size markers is indicated to the right. B Same blot as above hybridised with a 25S rRNA DNA probe.
- Figure 4 shows the nucleotide sequence and deduced amino acid sequence of the 4.6 kb SBEIc transcript produced in the wheat endosperm.
- Possible polyadenylation sequence is underlined and proposed transit peptide cleavage site is indicated by an vertical arrow. Shadowed regions represent conserved sequences in enzymes belonging to the ⁇ -amylase family 11 . Start of pRN60 sequence and location of PCR primers used in the study are indicated.
- FIG. 5 shows a schematic illustration of SBEIc precursor encoded by 4.6 kb Sbelc transcript.
- DNA sequences corresponding to exons 1 to 14 on wheat genomic Sbel 17 are indicated. Hatched areas indicate location of predicted transit peptide and domains 1 and 2 encompass SBEI-like sequences.
- the location of the four highly conserved regions on ( ⁇ ) ⁇ barrels of amylolytic enzymes 11 are indicated by black boxes and their sequences are shown below. Highly conserved residues are indicated by asterisks and catalytic residues present only on domain 2 are underlined.
- SBEIc is aligned with the SBEI-like protein deduced from the wSBEI-D2 cDNA 18 and the wheat 87 kD sBE ⁇ b i9 r ⁇ - ⁇ —
- Figure 6 shows the expression analysis of Sbelc in Eschenchia coli.
- BE activities were determined from the BE-positive strain DH5 ⁇ and the BE-deficient strain KV832, transformed with plasmids indicated.
- Construct pREP4-cm expresses the Lac repressor and pQE30 is a cloning vector used for construction of pQE-SBEIc.
- the BE activity values and standard errors determined by the phosphorylase a stimulation assay 20 are expressed as ⁇ mol glucose-1 -phosphate incorporated mg protein -1 min- 1 and were determined from three separate experiments.
- Figure 7 shows an immunoblot analysis of starch granule-bound proteins. A Analysis of starch granule-bound proteins by SDS-PAGE and silver staining. Migration of marker proteins (St) is shown to the left.
- Tigure ⁇ shows SDS-PAGE " analysis of starch” granule proteins produced in wheat endosperm.
- Figure 9 shows SDS-PAGE analysis of SGP extracted from wheat A- and B- type starch granules. Each lane was loaded with protein extract from 5 mg A- and B-type starch granules of five hexaploid and one tetraploid (Plenty) cultivar. Separated proteins were visualised by silver staining and migration of protein molecular weight markers (Mr) is indicated to the right.
- Mr protein molecular weight markers
- Figure 10 shows analysis of starch granule size distribution in wheat endosperm.
- Figure 11 shows SDS-PAGE analysis of SGP extracted from large-size (>10 ⁇ m) and small-size ( ⁇ 10 ⁇ m) starch granules of the hexaploid wheat cultivar CDC Teal. Samples of SGP from 5 mg starch granules were from different stages of wheat endosperm development as indicated. Gel-separated proteins were visualised by silver staining and migration of protein molecular weight marker (Mr) is indicated to the right.
- Mr protein molecular weight marker
- Figure 12 shows immunoblot analysis of extracted SGP from wheat A- and B-type starch granules. Each lane was loaded with SGP extracted from 2 mg A- and B-type starch granules harvested from mature endosperm of the hexaploid wheat cultivar CDC Teal. To the left is shown SGP separated by SDS-PAGE and visualised by silver staining. To the right is shown immunoblot analyses of gel-separated SGP using polyclonal antisera prepared against different wheat starch biosynthetic enzymes as indicated.
- FIG. 13 shows sub-cellular localisation of SGP-140 and SGP-145 in immature wheat kernels.
- SDS-PAGE analysis of SGP extracted from CDC Teal pericarp starch, endosperm starch and soluble endosperm proteins were prepared from different DPA of endosperm development as indicated.
- Samples of soluble protein [280 (10 DPA), 250 (15 DPA) or 250 (20 DPA) ⁇ g] and starch granules (5 mg) analysed were derived from the same amount of endosperm tissue.
- Gel-separated proteins were visualised by silver staining (pericarp and endosperm starch analysis) or Coomassie blue staining (soluble endosperm analysis). Migration of molecular weight marker (Mr) is shown to the right. Below is shown immunoreactive bands formed between gel-separated SGP- 140 and SGP-145 and wheat SBEI antibodies.
- Figure 14 shows analysis of SGP in starches from various plant sources.
- the inventors have characterised a cDNA encoding a novel form of SBEI in wheat endosperm.
- the encoded polypeptide was found to be preferentially associated with A-type starch granules. Isolation of a Partial SBEI cDNA Clone
- the 346 bp 5' sequence of pRN60 cDNA did not seem to encode a transit peptide, but instead matched sequences located further downstream on the same cDNA.
- the unusual 5' sequence carried by pRN60 lacked stop codons in frame with the downstream SBEI coding region, which suggested that the isolated cDNA could be translated from the first base, and therefore, might not represent a full-length transcript.
- the 4563 bp SBEI cDNA Encodes a Protein With Two SBEI-like Domains
- DNA sequence analysis of the 4563 bp Sbelc cDNA revealed an open reading frame of 1425 codons that was initiated from the 5' end of the assembled sequence and terminated at nucleotides 4278-4280.
- the TAA stop codon was followed by a possible polyadenylation signal sequence, AATAAA, located 19 bp upstream of the polyadenylation tail.
- Initiation of translation was assigned for the first ATG codon (nucleotides 63-65), allowing translation of 1405 codons of the open reading frame.
- Sequence analysis of the proposed ammo-terminal region of SBEIc revealed a 50% sequence identity to transit peptides predicted from wheat Sbela and Sbelb.
- SBEIc appeared, like the 87 kD SBEI, to be imported into plastids. Cleavage of the transit peptide was proposed to occur between amino acids Ala 6 7 and Ala 6 8 of the deduced SBEIc sequence (Ile-Ala-
- Wheat wSBEI-D2 is an SBE-like protein predicted to be produced in wheat endosperm 18 and SBEIb is deduced N-terminal sequence of 87 kD SBEI expressed in wheat endosperm 19 . Identical amino acids are highlighted.
- the first domain of SBEIc and the corresponding sequence on wSBEI-D2 differed from other characterised SBEI from plants at the four highly conserved regions on enzymes belonging to the ⁇ -amylase family, which include plant SBE 11 . It was especially notable that the Asp residues on regions two and four and the Glu residue on region three, all proposed to be directly involved in hydrolysis of ⁇ -1,4 glucan bonds 11 , were replaced by non-equivalent residues (Figure 5).
- the 152 kD SBEI is Associated with Starch Granules of the Wheat Endosperm
- the immunoblot analysis also revealed an interaction with the 92 kD protein band and several 62 to 67 kD protein bands of unknown identities. Since the 140 kD granule-bound protein corresponded reasonably well in mass to SBEIc and no SBEI corresponding in mass with SBEIc was found by immunoblot analysis of the soluble endosperm (data presented in Figure 13), the inventors reasoned that SBEIc was incorporated into starch granules. Further analysis of the granule-bound proteins using polyclonal antibodies prepared against a 87 kD wheat SBEII, revealed only an interaction with the 92 kD protein band (Figure 7B, lane ⁇ -SBEII), as previously reported by Rahman et al. (1995) 26 . Thus, isoforms analogous to SBEIc and bound to starch granules did not seem to exist for SBEII in wheat.
- SBEIc and its isoforms are preferentially associated with A-type starch granules of wheat endosperm.
- SBEIc Isoforms are Preferentially Associated with A-type Starch Granules in Wheat Endosperm
- the inventors compared starch granule proteins (SGPs) localised in A- and B-type starch granules, by purifying the two granule fractions from wheat endosperm-of six wheat cultivars using-a -method previously reported 27 .
- SGPs starch granule proteins
- the extracted SGPs were resolved by SDS-PAGE and visualised by silver staining.
- the 60 kD GBSSI was used as an internal standard for equal loading of proteins.
- A-type starch granules of all wheat cultivars tested contained a polypeptide co-migrating with SBEIc of Fielder ( Figure 9).
- Analysis of B-type starch granules from the six wheat cultivars showed a much lower abundance of the 140 and 145 kD polypeptides as compared to the A-type granules.
- B-type granules of the cultivar Fielder only the 140 kD band was observed.
- SGP-140 band which includes SBEIc in Fielder, and SGP-145 are preferentially associated with A-type starch granules.
- A-type starch granules are initiated at about four to 14 DPA, whereas B-type granules are formed after 14 DPA 4 30 . After initiation, both granule types continue to grow until maturity of the endosperm 31 .
- An image analysis of purified large-size and small-size starch granule fractions from developing endosperm of the cultivar CDC Teal showed that the growth of small starch granules formed before and after 15 DPA was significantly different (Figure 10). Prior to 15 DPA, the newly formed small starch granules grew rapidly in size to become large-size (>10 ⁇ m) starch granules ( Figure 10 A).
- SGP-140 and SGP-145 are Pre erentially Incorporated into A-type Starch Granules Throughout Endosperm Development
- SGP-140 and SGP-145 are preferential incorporation of SGP-140 and SGP-145 into A-type granules.
- the preferential incorporation of SGP-140 and SGP-145 into A-type granules can be explained by synthesis of these polypeptides only during the first 15 DPA.
- the inventors analysed the protein profiles of large-size and small-size granules isolated at different DPA ( Figure 11).
- the large-size (>10 ⁇ m) A-type starch granules were found to show no variation in SGP-140 and SGP-145 concentration during development.
- small-size B-type starch granules harvested after 15 DPA showed very low presence of SGP-140 and SGP-145.
- the analyses demonstrated no significant variation in concentration of the other major granule-bound polypeptides (60, 80, 92, 100, 108 and 115 kD) for both small-size and large-size starch granules throughout endosperm development.
- most of the A-type granule growth occurred after 15 DPA, when about 65% (w/w) of the starch in A-type granules was synthesized.
- the constant levels of SGP-140 and SGP-145 in A-type granules strongly suggested that the two proteins were continuously incorporated into A-type granules throughout endosperm development.
- SGP-140 plus SGP-145 in B-type granules is preferably at least about 4, more preferable at least about 5, most preferably at least about 10.
- SBEIc SGP-140 and SGP-145 protein bands of the wheat cultivar CDC Teal have very similar N-terminal sequences as SBEIc.
- Direct amino acid sequencing of the protein bands purified from SDS-PAGE gels suggested variation in amino acid sequence as indicated in Table I. This is likely due to presence of several polypeptides that differ slightly in sequence within the same protein band. Presence of several isoforms of SBEIc was also suggested by reverse transcription PCR analysis of transcripts produced in the cultivar Fielder.
- SGP-140 and SGP-145 in the developing kernels SGP from pericarp and endosperm starch granules, and the soluble endosperm fraction were prepared from developing wheat kernels, and analysed by SDS-PAGE and immunoblotting ( Figure 13). The results of these analyses confirmed that SGP-140 and SGP-145 were present within the endosperm starch granules, but could not be found in the endosperm soluble fraction. Nor were SGP-140 and SGP-145 observed in pericarp starch granules harvested from 5 to 10 DPA, but could be seen as two very faint bands in pericarp granules of 15 DPA.
- SGP-140 and/or SGP-145 Homologues Exist in Plant Species Known to Produce A- and B-type Starch Granules
- SDS-PAGE analysis of extracted SGP from triticale, barley and rye revealed one (barley and rye) or two protein bands (triticale) with similar relative mobility as SGP-140 and SGP-145 of wheat ( Figure 14 A). -These protein bands were-also-found to react with SBEI antibodies ( Figure 14B), and thus appeared to be SGP-140 and SGP-145 homologues.
- SBEIc encoded by the isolated cDNA differed from previously characterised SBEI isoforms by its high molecular mass and by the presence of two domains of SBEI-like sequences. Domain 1 differs from domain 2 by the lack of a 21 amino acid long peptide and a 163 residue long (-17 kD) C-terminal sequence ( Figure 5).
- SBEI transcripts produced in the developing wheat endosperm of the cultivar Fielder suggested that there are at least three different forms of SBEIc transcripts produced. These variants would encode proteins of very similar molecular masses ( ⁇ 1 kD difference), and thus, cannot be distinguished as separate bands on one-dimensional SDS-PAGE gels.
- Our analysis of starch granules of Triticum species suggested that variants of SBEIc also exist in both diploid (Triticum monococcum, Triticum tauschii) and tetraploid (Triticum turgidum ssp. durum) wheat (Figure 8B).
- INDUSTRIAL APPLICABILITY SEBIc is a novel starch branching enzyme. It can be used in vitro to synthesise or modify starch. Modified starches find use in the food and beverage industries as a thickener and sweetener, as well as in industrial uses, such as the production of stiffening agents for laundering, sizing for paper and as thickening agents and adhesives 32 33 .
- the Sbelc sequence, or fragments thereof, or complementary sequences to any of these can be used to screen plant genomes to locate genes that are homologous (i.e. which encode similar activities).
- SBEIc in a plant can be expected to result in modification of starch granule morphology and size distribution in seed endosperm.
- the Sbelc gene may be expressed in a plant already having a copy of this gene, in which case the expression SBEIc can be expected to increase.
- Increase in SBEIc expression may result in increase in A-type starch granule concentration, and/ or in increase in starch granule size.
- Cultivars having increased A-type granules would be desirable, for example, in the production of gluten, as A-type granules are more easily separated from the protein of the endosperm.
- Wheat starch with elevated A-granule content has applications in the manufacture of biodegradable plastic film and carbonless copy paper 34 .
- the invention also relates to homologous variants of SEQ ID NO: 1, including DNA sequences from plants encoding proteins with two SBEI-like domains, as illustrated in Figure 5, and deduced amino acid sequences of 25% or greater identity, and 40% or greater similarity, isolated and/ or characterised and/ or designed by known methods using the sequence information of SEQ ID NO:l or SEQ ID NO: 2, and to parts of reduced length that are able to function as inhibitors of gene expression by use in an anti-sense, co- suppression [Transwitch® gene suppression technology; U.S. patent no. 5,231,020, July 27, 1993; for reviews see Iyer et al.
- homologous variant when referring to a DNA sequence, encompasses all DNA sequences encoding a protein having the same functionality as the recited sequence, as well as those having two SBEI-like domains, illustrated in Figure 5.
- A-type starch granules Suppression of transcription and/ or translation of Sbelc, for example, by — using anti-sense approaches, would be expected to reduce the concentration of A-type starch granules. Reduction in A-type granules is desirable if the starch is going to be used as face powder, as a laundry-stiffening agent, a fat replacement or in the production of degradable plastic films 39 40 .
- probes based on the sequence of Sbelc (SEQ ID NO: 1) or complementary sequences may be used to screen the genome of existing cultivars to find those cultivars having within their genome homologues (particularly alleles) of Sbelc, encoding SBEs that are preferentially bound to A-type starch granules.
- Such cultivars can be chosen for crossbreeding with one-another, resulting in progeny strains having a high level of SBEIc or homologue expression.
- cultivars having a low level of Stele-like sequences within their genome can be expected to have a low level of A-type starch granules.
- Such cultivars could be chosen for crossbreeding with one-another, resulting in progeny strains having a low level of SBEIc expression, and a reduced content of A-type starch granules.
- strains expressing SBEIc or homologous variants can be found using antibodies raised to SBEIc (polyclonal or monoclonal) to screen cereal varieties to find those having SBEIc or variants.
- Antibodies to SBEIc can be produced by known methods 41 42 43 u .
- the invention also relates to a method of genetically transforming a plant so that the plant expresses a starch branching enzyme that is bound to A-type starch granules in wheat, barley, or triticale endosperm.
- the invention also relates to a genetically modified plant having within its genome a hybrid gene, wherein the hybrid gene comprises a DNA sequence encoding a starch branching enzyme that is bound to A-type starch granules in wheat, barley or triticale endosperm, or a fragment thereof, fused to a passenger-gene.
- the protein encoded by the hybrid gene is preferably targeted to starch granules.
- the passenger-gene preferably encodes a vaccine, an antibody, a pigment, a preservative, a fragrant or flavour inducing agent, a receptor, or an enzyme involved in lipid, carbohydrate or protein synthesis, degradation or modification.
- IPTG isopropyl ⁇ -D-thiogalactopyranoside
- RT-PCR reverse transcription -polymerase chain reaction
- Probe 1 used in the library screening consisted of an 828 bp Reverse Transcription-PCR (RT-PCR) product, obtained from a reaction using 12 day old wheat kernel RNA and the Sbel -specific primers BE11 and BE12 ( Figures 1 and 4). The primers were based on sequences of previously characterised Sbel clones from wheat 17 19 . Ten of the positive clones were plaque-purified and their inserts were excised in vivo from the Uni-ZAP XRTM vector (Stratagene). The clone with the longest insert was denoted pRN60 and chosen for further characterisation.
- RT-PCR Reverse Transcription-PCR
- Templates for sequencing were prepared by subcloning DNA fragments into the pBluescript II SK + vector (Stratagene). DNA sequencing reactions were performed by the dye terminator cycle sequencing technique and analysed on an automated DNA Sequencer (Applied Biosystems, Foster City, CA). All reported sequences were determined on both strands and from overlapping templates. Nucleotide sequences were assembled and analysed using the Laser geneTM software (DNASTAR Inc.). Pair- wise alignments of DNA and protein sequences were calculated by the Clustal method using a ktuple value 1, gap penalty value 3 and window size 5.
- RNA gel blot analysis was performed with 20 ⁇ g total RNA fractionated on a 1 % agarose-2.2 M formaldehyde gel, transferred to a HybondTM (Amersham) membrane, hybridised with probe 2 (nucleotides 1993 to 4209 of Sbelc; Figure 1) and washed as described by Nair et al. (1997) 60 . To assure that about the same amount of RNA was loaded onto each lane, the hybridised blot was stripped and rehybridised with a 25S ribosomal DNA probe as described 60 . Probes were radio-labelled using the RediprimeTM random primer labelling kit from Amersham. 5'-RACE
- 5'-RACE was performed with poly(A) + RNA extracted from 12-day-old wheat endosperm following the protocol supplied with the MarathonTM cDNA Amplification Kit from Clontech.
- the first strand synthesis was primed with the Sbel -specific BE19 primer ( Figures 3 and 4).
- the double-stranded cDNA was ligated to the Marathon cDNA Adapter (Clontech), followed by a first round PCR amplification performed with the adapter primer API (5'-CCATCCTAATACGACTCACTATAGGGC- 3'; Clontech) and the Stel-specific primer BE25 ( Figures 3 and 4).
- the reaction was initiated by a denaturation step at 94°C for 3 min followed, by 25 cycles of 94°C 30 sec, 62°C 20 sec and 68°C 3 min and a final 10 min extension at 68°C.
- Products derived from the 4.8 kb Sbel transcripts were separated from shorter products derived from the 2.8 kb Sbel mRNA by agarose gel electrophoresis.
- Products of 1.9 to 2.7 kb were gel-purified and used as a template in a nested amplification employing nested adapter primer AP2 (5'-ACTCACTATAGGGCTCGAGCGGC-3'; Clontech) and the gene-specific primer BE39 ( Figures 3 and 4).
- the amplification conditions were 94°C 3 min, 30 cycles of 94°C 30 sec, 65°C 20 sec and 68°C 3 min, followed by a final extension at 68°C for 10 min. Amplified fragments were separated by agarose gel electrophoresis, isolated, cloned and analysed by DNA sequencing.
- First strand cDNA used as a template in the RT-PCR reactions, was synthesised from 1.0 ⁇ g total RNA isolated from 12-day-old wheat endosperm. The RNA was primed with oligo(dT) 12 . 1 8 and reverse- transcribed in a total volume of 20 ⁇ l using SuperscriptTM II (Gibco-BRL). PCR reactions (25 ⁇ l) were performed with a 0.5 ⁇ l aliquot of the first-strand cDNA using the Long Expand TemplateTM PCR System (Boehringer Mannheim) and the primer pair BE65/BE38 ( Figures 3 and 4).
- Reactions were initiated by a denaturation step at 94°C for 3 min, followed by 30 cycles of 94°C 30 sec, 65°C 20 sec, 68°C 2 min 30 sec and a final 10 min extension at 68°C Amplified fragments were fractionated by agarose gel electrophoresis, isolated, cloned and analysed by DNA sequencing.
- pREP4-cm encoding the Lac repressor
- pREP4 Qiagen
- pKKABEI encoding the mature 87 kD wheat SBEI
- pKK388-l bacterial expression vector
- pRN33 60 nucleotides 317-1442 carried by a Haelll fragment were inserted into a filled-in BamHI site of the His-tag expression vector pQE31 (Qiagen).
- the resulting construct was restricted with Kpnl and Smal, followed by introduction of nucleotides 1245-2632 located on a Kpnl-PvuII fragment, to give pQRN33.
- the BE activity levels in cells from non-induced cultures was determined by the phosphorylase a stimulation assay 20 performed at 30°C for 30 min using two and five ⁇ g of soluble protein extract.
- the cell extracts were prepared from cells of 1 ml culture that were lysed by sonication in 0.25 ml extraction buffer (50 mM Tris-HCl pH 7.5, 2 mM EDTA, 5 mM DTT, 1 mM phenylmethylsulfonyl fluoride) and centrifuged at 15,000 x g for 20 min. Determination of protein concentration in the soluble extracts was done using the dye-binding assay (Bio-Rad).
- the final protein extract was loaded onto a 10% preparative SDS-PAGE gel and the 87 kD SBEI band was isolated by electroelution (Model 422 Electro-eluterTM, Bio-Rad).
- the protein eluate was concentrated using a Centriplus-30TM column (Amicon) before "" immunisation.
- Starch granules were isolated from mature endosperm of five hexaploid wheat cultivars (Triticum aestivum L. cv. CDC Teal, McKenzie, AC Karma, AC Crystal, and Fielder), one tetraploid wheat (Triticum turgidum L. cv. Plenty) cultivar, barley (Hordeum vulgare L.), rye (Secale cereale L.), triticale (X Triticosecale Wittmack), rice (Oryza sativa L.), maize (Zea mays L.), canary seed (Phalaris canariensis L.) and potato (Solanum tuberosum L.) tubers as described by Peng et al.
- the endosperm and pericarp fractions were homogenised with a mortar and pestle in three volumes of extraction buffer B and filtered through four layers of MiraclothTM (Calbiochem) to remove cell debris.
- the crude starch granule fraction was pelleted by centrifugation at 15,000 x g for 30 min and further purified as described 27 .
- the endosperm starch granules were separated into large-size (diameter >10 ⁇ m) and small-size (diameter ⁇ 10 ⁇ m) fractions and studied by image analysis as described 27 .
- the supernatant remaining from centrifugation of the homogenised endosperm (see above) constituted the endosperm soluble fraction.
- Protein concentration in the extract was determined using a dye-binding assay from Bio-Rad. For each endosperm fraction, the total amount of extracted soluble protein was determined.
- Extracted total starch (10 mg) was resuspended in 150 ⁇ l of sample buffer (62.5 mM Tris-HCl pH 8.0, 10% SDS, 10% glycerol, 5% ⁇ -mercaptoethanol and 0.005% bromophenol blue), boiled for 7 min, cooled on ice for 5 min and centrifuged at 15,000 x g for 20 min.
- sample buffer 62.5 mM Tris-HCl pH 8.0, 10% SDS, 10% glycerol, 5% ⁇ -mercaptoethanol and 0.005% bromophenol blue
- Extracted A-type and B-type starch granules ( 50 mg) were suspended in 350 ⁇ l extraction buffer A [62.5 mM Tris-HCl, pH 6.8, 10% (w/v) SDS, 5% (v/v) ⁇ -mercaptoethanol], boiled for 15 min, cooled to room temperature, and centrifuged at 15,000 x g for 20 min. SDS-PAGE analysis of total and size fractionated starch granules was done on 10% resolving gels (30:0.135) and proteins were visualized by Coomassie blue staining and/ or silver staining (BIO-RAD).
- SGP were extracted from 10 g A-type starch granules of CDC Teal and resolved on preparative SDS-PAGE gels.
- the migration of SGP-140 and SGP- 145 was determined by silver staining a slice of the gel.
- the proteins were eluted from the unstained part of the gel using an electro-eluter (Model 422 Electro-EluterTM, BIO-RAD) and elution buffer (25 mM Tris, 192 mM glycine, 0.1% SDS).
- the eluate was dialysed for 8 h against 21 of dialysis buffer (50 mM Tris-acetate, pH 6.8, 5 mM DTT), with one buffer change.
- the dialysed solution was concentrated to 500 ⁇ l through ultrafiltration (Amicon 100), and 200 ⁇ l of the concentrate was loaded on a preparative SDS-PAGE gel. Gel- separated proteins were blotted on a PVDF membrane, as described above. SGP-140 and SGP-145 were identified by amido black staining and subjected to N-terminal sequencing using a gas-phase protein sequencer (Applied Biosystem Model 476 A).
- SEQ ID NO: 1 is the DNA sequence of Sbelc
- SEQ ID NO: 2 is the amino acid sequence of SBEIc
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Nutrition Science (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU11227/01A AU1122701A (en) | 1999-10-29 | 2000-10-27 | Starch branching enzymes |
US10/110,777 US7041484B1 (en) | 1999-10-29 | 2000-10-27 | Starch branching enzymes |
CA002389390A CA2389390A1 (en) | 1999-10-29 | 2000-10-27 | Starch branching enzymes |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16214499P | 1999-10-29 | 1999-10-29 | |
US60/162,144 | 1999-10-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001032886A2 true WO2001032886A2 (en) | 2001-05-10 |
WO2001032886A3 WO2001032886A3 (en) | 2001-11-29 |
Family
ID=22584342
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CA2000/001276 WO2001032886A2 (en) | 1999-10-29 | 2000-10-27 | Starch branching enzymes |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU1122701A (en) |
CA (1) | CA2389390A1 (en) |
WO (1) | WO2001032886A2 (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7521593B2 (en) | 2002-05-09 | 2009-04-21 | Commonwealth Scientific And Industrial Research Organisation | Barley with altered branching enzyme activity and starch and starch containing products with an increased amylose content |
US7700826B2 (en) | 1999-04-29 | 2010-04-20 | Commonwealth Scientific And Industrial Ressearch Organization | Genes encoding wheat starch synthases and uses thereof |
US7700139B2 (en) | 2004-12-30 | 2010-04-20 | Commonwealth Scientific And Industrial Research Organization | Method and means for improving bowel health |
US7790955B2 (en) | 2003-10-27 | 2010-09-07 | The Commonwealth Of Australia Commonwealth Scientific And Industrial Research Organisation | Rice and products thereof having starch with an increased proportion of amylose |
US7888499B2 (en) | 2000-11-09 | 2011-02-15 | Commonwealth Scientific And Industrial Research Organization | Barley with reduced SSII activity and starch containing products with a reduced amylopectin content |
EP2290084A2 (en) | 2003-06-30 | 2011-03-02 | Commonwealth Scientific and Industrial Research Organization | Wheat with altered branching enzyme activity and starch and starch containing products derived therefrom |
US7993686B2 (en) | 2004-12-30 | 2011-08-09 | Commonwealth Scientific And Industrial Organisation | Method and means for improving bowel health |
US9060533B2 (en) | 2010-11-04 | 2015-06-23 | Arista Cereal Technologies Pty Limited | High amylose wheat |
US9357722B2 (en) | 2011-11-04 | 2016-06-07 | Arista Cereal Technologies Pty Limited | High amylose wheat-II |
US9752157B2 (en) | 2008-07-17 | 2017-09-05 | Commonwealth Scientific And Industrial Research Organisation | High fructan cereal plants |
US9826764B2 (en) | 2011-02-03 | 2017-11-28 | Commonwealth Scientific And Industrial Research Organisation | Production of food and beverage products from barley grain |
US10154632B2 (en) | 2009-07-30 | 2018-12-18 | Commonwealth Scientific And Industrial Research Organisation | Barley and uses thereof |
US10246717B2 (en) | 2011-10-04 | 2019-04-02 | Arcadia Biosciences, Inc. | Wheat with increased resistant starch levels |
US11572581B2 (en) | 2002-06-07 | 2023-02-07 | DNA Genotek, Inc. | Compositions and methods for obtaining nucleic acids from sputum |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69233352T2 (en) * | 1992-10-14 | 2004-10-07 | Syngenta Ltd | PLANTS AND METHOD FOR THEIR PRODUCTION |
DE69637816D1 (en) * | 1995-12-20 | 2009-03-05 | Du Pont | THE EXPRESSION OF GENES WHICH ARE SPECIFIC FOR STRENGTH BIOSYNTHESIS |
DE69738587T2 (en) * | 1996-09-30 | 2009-04-30 | Basf Plant Science Gmbh | Encapsulation of Polypepidines in the Stem Matrix |
US6916976B1 (en) * | 1997-09-12 | 2005-07-12 | Commonwealth Scientific & Industrial Research Organisation | Regulation of gene expression in plants |
-
2000
- 2000-10-27 CA CA002389390A patent/CA2389390A1/en not_active Abandoned
- 2000-10-27 AU AU11227/01A patent/AU1122701A/en not_active Abandoned
- 2000-10-27 WO PCT/CA2000/001276 patent/WO2001032886A2/en active Application Filing
Cited By (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7700826B2 (en) | 1999-04-29 | 2010-04-20 | Commonwealth Scientific And Industrial Ressearch Organization | Genes encoding wheat starch synthases and uses thereof |
US8178759B2 (en) | 2000-11-09 | 2012-05-15 | Commonwealth Scientific And Industrial Research Organisation | Barely with reduced SSII activity and starch and starch containing products with a reduced amylopectin content |
US7888499B2 (en) | 2000-11-09 | 2011-02-15 | Commonwealth Scientific And Industrial Research Organization | Barley with reduced SSII activity and starch containing products with a reduced amylopectin content |
US7521593B2 (en) | 2002-05-09 | 2009-04-21 | Commonwealth Scientific And Industrial Research Organisation | Barley with altered branching enzyme activity and starch and starch containing products with an increased amylose content |
US7919132B2 (en) | 2002-05-09 | 2011-04-05 | Commonwealth Scientific And Industrial Research Organisation | Barley with altered branching enzyme activity and starch and starch containing products with an increased amylose content |
US11572581B2 (en) | 2002-06-07 | 2023-02-07 | DNA Genotek, Inc. | Compositions and methods for obtaining nucleic acids from sputum |
EP2290084A2 (en) | 2003-06-30 | 2011-03-02 | Commonwealth Scientific and Industrial Research Organization | Wheat with altered branching enzyme activity and starch and starch containing products derived therefrom |
US7790955B2 (en) | 2003-10-27 | 2010-09-07 | The Commonwealth Of Australia Commonwealth Scientific And Industrial Research Organisation | Rice and products thereof having starch with an increased proportion of amylose |
US8188336B2 (en) | 2003-10-27 | 2012-05-29 | Commonwealth Scientific And Industrial Research Organisation | Rice and products thereof having starch with an increased proportion of amylose |
US9212351B2 (en) | 2003-10-27 | 2015-12-15 | Commonwealth Scientific And Industrial Research Organisation | Rice and products thereof having starch with an increased proportion of amylose |
US7993686B2 (en) | 2004-12-30 | 2011-08-09 | Commonwealth Scientific And Industrial Organisation | Method and means for improving bowel health |
US8501262B2 (en) | 2004-12-30 | 2013-08-06 | Commonwealth Scientific And Industrial Research Organisation | Method and means for improving bowel health |
US7700139B2 (en) | 2004-12-30 | 2010-04-20 | Commonwealth Scientific And Industrial Research Organization | Method and means for improving bowel health |
US11111498B2 (en) | 2008-07-17 | 2021-09-07 | Commonwealth Scientific And Industrial Research Organisation | High fructan cereal plants |
US9752157B2 (en) | 2008-07-17 | 2017-09-05 | Commonwealth Scientific And Industrial Research Organisation | High fructan cereal plants |
US12241073B2 (en) | 2008-07-17 | 2025-03-04 | Commonwealth Scientific And Industrial Research Organisation | High fructan cereal plants |
US11026384B2 (en) | 2009-07-30 | 2021-06-08 | The Healthy Grain Pty Limited | Barley and uses thereof |
US10154632B2 (en) | 2009-07-30 | 2018-12-18 | Commonwealth Scientific And Industrial Research Organisation | Barley and uses thereof |
US9585413B2 (en) | 2010-11-04 | 2017-03-07 | Arista Cereal Technology Pty Limited | Food ingredients produced from high amylose wheat |
US12075806B2 (en) | 2010-11-04 | 2024-09-03 | Arista Cereal Technologies Pty Limited | Food ingredients produced from high amylose wheat |
US9060533B2 (en) | 2010-11-04 | 2015-06-23 | Arista Cereal Technologies Pty Limited | High amylose wheat |
US11304432B2 (en) | 2010-11-04 | 2022-04-19 | Arista Cereal Technologies Pty Limited | Food ingredients produced from high amylose wheat |
US10212959B2 (en) | 2011-02-03 | 2019-02-26 | Commonwealth Scientific And Industrial Research Organisation | Production of food and beverage products from barley grain |
US11266171B2 (en) | 2011-02-03 | 2022-03-08 | The Healthy Grain Pty Limited | Production of food and beverage products from barley grain |
US9826764B2 (en) | 2011-02-03 | 2017-11-28 | Commonwealth Scientific And Industrial Research Organisation | Production of food and beverage products from barley grain |
US10934557B2 (en) | 2011-10-04 | 2021-03-02 | Arcadia Biosciences, Inc. | Wheat with increased resistant starch levels |
US10563217B2 (en) | 2011-10-04 | 2020-02-18 | Arcadia Biosciences, Inc. | Wheat with increased resistant starch levels |
US10246716B2 (en) | 2011-10-04 | 2019-04-02 | Arcadia Biosciences, Inc. | Wheat with increased resistant starch levels |
US11649464B2 (en) | 2011-10-04 | 2023-05-16 | Arcadia Biosciences, Inc. | Wheat with increased resistant starch levels |
US10246717B2 (en) | 2011-10-04 | 2019-04-02 | Arcadia Biosciences, Inc. | Wheat with increased resistant starch levels |
US12319920B2 (en) | 2011-10-04 | 2025-06-03 | Arcadia Biosciences, Inc. | Wheat with increased resistant starch levels |
US9357722B2 (en) | 2011-11-04 | 2016-06-07 | Arista Cereal Technologies Pty Limited | High amylose wheat-II |
Also Published As
Publication number | Publication date |
---|---|
CA2389390A1 (en) | 2001-05-10 |
WO2001032886A3 (en) | 2001-11-29 |
AU1122701A (en) | 2001-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Salehuzzaman et al. | Isolation and characterization of a cDNA encoding granule-bound starch synthase in cassava (Manihot esculenta Crantz) and its antisense expression in potato | |
Harn et al. | Isolation and characterization of the zSSIIa and zSSIIb starch synthase cDNA clones from maize endosperm | |
Marshall et al. | Identification of the major starch synthase in the soluble fraction of potato tubers. | |
CA2603919C (en) | High-phosphate starch | |
US7041484B1 (en) | Starch branching enzymes | |
Abel et al. | Cloning and functional analysis of a cDNA encoding a novel 139 kDa starch synthase from potato (Solanum tuberosum L.) | |
JP5284261B2 (en) | Genetically modified plants that synthesize starches with increased swelling power | |
JP5812978B2 (en) | Plants with increased activity of multiple starch phosphatases | |
JP4148964B2 (en) | DNA molecules encoding enzymes involved in starch synthesis, and vectors, bacteria, transgenic plant cells and transgenic plants containing the DNA molecules | |
US7112718B2 (en) | Transgenic plants synthesizing high amylose starch | |
Knight et al. | Molecular cloning of starch synthase I from maize (W64) endosperm and expression in Escherichia coli | |
US7989677B2 (en) | Nucleic acids and proteins associated with sucrose accumulation in coffee | |
Larsson et al. | Three isoforms of starch synthase and two isoforms of branching enzyme are present in potato tuber starch | |
Ji et al. | Microbial starch-binding domains as a tool for targeting proteins to granules during starch biosynthesis | |
US7667114B2 (en) | Starch branching enzyme | |
KR20000011160A (en) | Nucleic acid molecules coding soluble maize starch synthases | |
WO2001032886A2 (en) | Starch branching enzymes | |
Båga et al. | Isolation of a cDNA encoding a granule-bound 152-kilodalton starch-branching enzyme in wheat | |
US8217226B2 (en) | Nucleic acids and proteins associated with galactomannan synthesis in coffee | |
Peng et al. | Isolation, characterization and expression analysis of starch synthase I from wheat (Triticum aestivum L.) | |
CA2515200C (en) | Galacturonosyltransferases, nucleic acids encoding same and uses therefor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2389390 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10110777 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |